SEC Form 4 · accession 0001161697-15-000039
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D Muth
Officer — EVP, Chief Commercial Officer
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Jan 20, 2015 | P | 21,000 | $2.9559 | A | 41,000 | D |
Table II — derivative securities
No Table II lines on this filing.